A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery

Study Identifier
206207-027
CT.gov Identifier
NCT01605942
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Other
Sign up for trial alerts

Study Details

Medical Condition
  • Eye Care - Other
    • Study Drug
  • Dexamethasone Drug Delivery System
  • Placebo Drug Delivery System
    • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Planned single cataract extraction with lens implant * Best-corrected visual acuity of 20/200 or better in the opposite eye
    Exclusion Criteria:
    * Glaucoma or history of intraocular hypertension in the study eye * History of chronic ocular allergy in the last year requiring treatment * Scheduled for cataract surgery in the non-study eye during study participation

    Protocol Summary

    This is a safety and efficacy study of a Dexamethasone Drug Delivery System for anterior segment inflammation and pain following cataract extraction with lens implantation.

    Study Locations

    Location
    Status
    Location
    Newport Beach, California, United States
    Status
    Not applicable